Surgery Partners Inc (SGRY) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.56 is considered Undervalued compared with the five-year average of -331.54. The fair price of Surgery Partners Inc (SGRY) is between 18.91 to 34.36 according to relative valuation method. Compared to the current price of 13.92 USD , Surgery Partners Inc By Undervalued By 26.37%.

Relative Value

Fair Zone

18.91-34.36

Current Price：13.92

26.37%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Surgery Partners Inc (SGRY) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Surgery Partners Inc (SGRY) has a current Price-to-Book (P/B) ratio of 1.13. Compared to its 3-year average P/B ratio of 1.82, the current P/B ratio is approximately -37.89% higher. Relative to its 5-year average P/B ratio of 3.08, the current P/B ratio is about -63.29% higher. Surgery Partners Inc (SGRY) has a Forward Free Cash Flow (FCF) yield of approximately 9.90%. Compared to its 3-year average FCF yield of 4.96%, the current FCF yield is approximately 99.78% lower. Relative to its 5-year average FCF yield of 3.97%, the current FCF yield is about 149.16% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for SGRY competitors is 0.33, providing a benchmark for relative valuation. Surgery Partners Inc Corp (SGRY.O) exhibits a P/S ratio of 0.56, which is 72.17% above the industry average. Given its robust revenue growth of 2.38%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of SGRY increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of SGRY in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is SGRY currently overvalued or undervalued?

What is Surgery Partners Inc (SGRY) fair value?

SGRY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Surgery Partners Inc (SGRY) is between 18.91 to 34.36 according to relative valuation method.

How does SGRY's valuation metrics compare to the industry average?

The average P/S ratio for SGRY's competitors is 0.33, providing a benchmark for relative valuation. Surgery Partners Inc Corp (SGRY) exhibits a P/S ratio of 0.56, which is 72.17% above the industry average. Given its robust revenue growth of 2.38%, this premium appears unsustainable.

What is the current P/B ratio for Surgery Partners Inc (SGRY) as of Mar 03 2026?

As of Mar 03 2026, Surgery Partners Inc (SGRY) has a P/B ratio of 1.13. This indicates that the market values SGRY at 1.13 times its book value.

What is the current FCF Yield for Surgery Partners Inc (SGRY) as of Mar 03 2026?

As of Mar 03 2026, Surgery Partners Inc (SGRY) has a FCF Yield of 9.90%. This means that for every dollar of Surgery Partners Inc's market capitalization, the company generates 9.90 cents in free cash flow.

What is the current Forward P/E ratio for Surgery Partners Inc (SGRY) as of Mar 03 2026?

As of Mar 03 2026, Surgery Partners Inc (SGRY) has a Forward P/E ratio of 24.62. This means the market is willing to pay $24.62 for every dollar of Surgery Partners Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Surgery Partners Inc (SGRY) as of Mar 03 2026?

As of Mar 03 2026, Surgery Partners Inc (SGRY) has a Forward P/S ratio of 0.56. This means the market is valuing SGRY at $0.56 for every dollar of expected revenue over the next 12 months.

SGRY Valuation